Cerapedics Leadership Team

Glen Kashuba, CEO

Glen has over 30 years of executive management experience within market leading device companies. Prior to becoming CEO in 2013, Glen served as Worldwide President of Spine & Bone Healing Technologies, Inc., a Biomet company, and concurrently served as Senior Vice President on Biomet’s Worldwide Operating Board, encompassing Biomet’s orthopedics, spine, trauma, biologics and sports medicine businesses. He also served as Worldwide President for Biomet Spine and Trauma. During his tenure at Biomet, he launched more than 25 new products. Prior to Biomet, Glen held a number of division president roles at Johnson & Johnson, including Worldwide President of Cordis Endovascular, Cordis Neurovascular and Codman Neuro Sciences, and U.S. President of DePuy Spine.

Jeffrey G. Marx, Ph.D., President & COO

Jeff offers Cerapedics vast experience in research & development, commercialization, sales management, business development and strategic planning. Jeff formerly served as Vice President, Corporate Development at Orthovita and as a member of the senior leadership team during his 13-year tenure. Following the acquisition of Orthovita by Stryker, Jeff led the integration of Orthovita into Stryker and served as Vice President of Corporate Development at Stryker Orthobiologics.

Drew Trivisonno, CFO

Drew has more than 20 years of experience in the management of financial operations activities, and has spent the past 10 years focused on M&A and raising capital within the medical device marketplace. Drew has been involved in more than 15 equity and debt finance transactions raising several hundred million dollars partnering with global leaders in the debt and equity financings space. Prior to his experience in the medical device space, Drew held various positions in the investment banking industry, including Furman Selz and Merrill Lynch.

Jerome Connor, Ph.D., VP of Research and Development

Dr. Connor spent 22 years at LifeCell Corporation as the Senior Director of Research and Development. He brings over 30 years of academic and commercial experience in basic research and product development in the fields of soft tissue, hard tissue, and cell-based biology.

Roger N. White, VP of Clinical and Regulatory Affairs

Roger has over 30 years of experience in the medical device industry, including extensive regulatory, clinical and product development experience with Sofamor Danek, Medtronic, Spine Wave and multiple early-stage companies. His experience includes establishing and executing regulatory strategies for both the U.S. and European markets.

Andrew W. Barnes, VP of U.S. Sales

Andy has held sales leadership positions with leading biologics, spine, orthopedic and maxillofacial companies during his 25 years in the medical device field. Prior to joining Cerapedics, Andy led teams at Globus Medical, Stryker Orthobiologics/Orthovita, Medtronic and MacroPore Biosurgery after starting his successful sales career with Synthes Trauma, Spine & Maxillofacial.

Troy Wilford, Director of Marketing

Troy has more than 15 years experience creating and implementing brand commercialization strategies at key industry leaders like Johnson & Johnson and Stryker. While at these and several early stage companies, Troy honed his expertise blending strategic planning and tactical execution in areas such as market research, market development, product launch and channel effectiveness in support of major platforms in orthopedics, neurosurgery, spine, orthobiomaterials and regenerative medicine.

Andy Woods, Director of Commercial Development

Andy, based in the UK, has more than 25 years of experience developing markets and growing market share for biomaterials companies throughout Europe and International Markets.

Scott Johnson, Ph.D., Director of Clinical Education and Marketing

Scott has over 15 years of experience in the medical device industry. Scott’s perspective spans the technical and commercial with a breadth of experience that includes roles within research and development, product innovation and clinical and business development. Educated in the UK, Scott holds a BSc and PhD with research interests in musculoskeletal biology and biomechanics.

Katie Davis, Director of Research and Development 

Katie has more than 15 years of experience in medical device R&D. With a Master’s degree in Chemical Engineering, Katie utilizes her decade of involvement with P-15 technology to further develop the i-FACTORTM bone graft portfolio.

Mark Bowerman, Director of Quality Systems and Regulatory Affairs

Mark has over 30 years of experience in the medical device industry including R&D, quality, and regulatory for both ground level start-ups and large corporations such as Baxter and Dentsply.  He has developed and implemented quality management systems that are adaptable to company needs and compliant with regulations.  He has executed regulatory strategies and obtained market clearance/approvals for numerous products in both the international and U.S. markets.